AG˹ٷ

STOCK TITAN

[Form 4] CRA International, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CRA International (CRAI) Form 4 filing: Director Christine Rose Detrick received 696 shares of common stock on 17 Jul 2025 at $0, lifting her direct ownership to 6,139 shares. The award is restricted stock that vests 25% annually starting on the first anniversary of the grant, encouraging long-term alignment with shareholders. No derivatives were exercised and no shares were sold or transferred. The addition raises the director’s stake by about 13% but represents well under 0.01% of the company’s outstanding shares, so dilution and market impact are negligible. While insider accumulation is directionally positive, the economic value is modest and does not materially alter CRAI’s capital structure or investment thesis.

Deposito del Modulo 4 di CRA International (CRAI): La direttrice Christine Rose Detrick ha ricevuto 696 azioni ordinarie il 17 luglio 2025 al prezzo di $0, portando la sua partecipazione diretta a 6.139 azioni. Il premio consiste in azioni vincolate che maturano il 25% ogni anno a partire dal primo anniversario della concessione, favorendo un allineamento a lungo termine con gli azionisti. Non sono stati esercitati derivati né sono state vendute o trasferite azioni. L'incremento aumenta la quota della direttrice di circa il 13%, ma rappresenta meno dello 0,01% delle azioni in circolazione della società, quindi la diluizione e l'impatto sul mercato sono trascurabili. Sebbene l'accumulo interno sia un segnale positivo, il valore economico è modesto e non modifica sostanzialmente la struttura del capitale o la tesi di investimento di CRAI.

Presentación del Formulario 4 de CRA International (CRAI): La directora Christine Rose Detrick recibió 696 acciones comunes el 17 de julio de 2025 a $0, elevando su propiedad directa a 6,139 acciones. La concesión consiste en acciones restringidas que se consolidan en un 25% anual a partir del primer aniversario de la adjudicación, promoviendo una alineación a largo plazo con los accionistas. No se ejercieron derivados ni se vendieron o transfirieron acciones. Esta adición incrementa la participación de la directora en aproximadamente un 13%, pero representa menos del 0,01% de las acciones en circulación de la compañía, por lo que la dilución y el impacto en el mercado son insignificantes. Aunque la acumulación interna es un indicio positivo, el valor económico es modesto y no altera materialmente la estructura de capital ni la tesis de inversión de CRAI.

CRA International (CRAI) Form 4 제출: 이사 Christine Rose Detrick� 2025� 7� 17일에 보통� 696주를 $0� 수령하여 직접 소유 지분을 6,139주로 늘렸습니�. � 수여� 제한 주식으로, 부여일로부� 1주년부� 매년 25%� 베스팅되� 주주와� 장기적인 정렬� 장려합니�. 파생상품 행사� 없었� 주식� 매도 또는 이전되지 않았습니�. 이번 추가� 이사� 지분은 � 13% 증가했으�, 회사� 발행 주식 총수� 0.01% 미만� 해당하여 희석 � 시장 영향은 미미합니�. 내부� 매입은 긍정적인 신호이나 경제� 가치는 크지 않아 CRAI� 자본 구조� 투자 논리� 실질적인 변화를 주지 않습니다.

Dépôt du Formulaire 4 de CRA International (CRAI) : La directrice Christine Rose Detrick a reçu 696 actions ordinaires le 17 juillet 2025 à 0 $, portant sa participation directe à 6 139 actions. Cette attribution concerne des actions restreintes qui acquièrent 25 % de droits chaque année à partir du premier anniversaire de la remise, favorisant un alignement à long terme avec les actionnaires. Aucun dérivé n’a été exercé et aucune action n’a été vendue ou transférée. Cette augmentation porte la participation de la directrice à environ 13 %, mais représente bien moins de 0,01 % des actions en circulation de la société, rendant la dilution et l’impact sur le marché négligeables. Bien que l’accumulation interne soit un signe positif, la valeur économique reste modeste et ne modifie pas de manière significative la structure du capital ni la thèse d’investissement de CRAI.

CRA International (CRAI) Form 4 Einreichung: Direktorin Christine Rose Detrick erhielt am 17. Juli 2025 696 Stammaktien zu $0, wodurch ihr Direktbesitz auf 6.139 Aktien anstieg. Die Zuteilung besteht aus eingeschränkten Aktien, die ab dem ersten Jahrestag der Gewährung jährlich zu 25 % freigegeben werden, um eine langfristige Ausrichtung an den Aktionären zu fördern. Es wurden keine Derivate ausgeübt und keine Aktien verkauft oder übertragen. Die Hinzufügung erhöht den Anteil der Direktorin um etwa 13 %, stellt jedoch weniger als 0,01 % der ausstehenden Aktien des Unternehmens dar, sodass Verwässerung und Markteinfluss vernachlässigbar sind. Obwohl die Insider-Akkumulation positiv zu werten ist, ist der wirtschaftliche Wert moderat und ändert die Kapitalstruktur oder Investmentthese von CRAI nicht wesentlich.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small restricted-stock grant to director; positive signal but economically immaterial.

The Form 4 shows a routine board equity grant�696 shares valued at roughly US$0.1 m—awarded to Director Christine Rose Detrick. Her total direct holdings rise to 6,139 shares, maintaining governance alignment without meaningful dilution. Because the grant value is de minimis relative to CRAI’s market cap and no cash purchase occurred, I view the filing as neutral for valuation or near-term stock performance, though it modestly reinforces insider confidence.

Deposito del Modulo 4 di CRA International (CRAI): La direttrice Christine Rose Detrick ha ricevuto 696 azioni ordinarie il 17 luglio 2025 al prezzo di $0, portando la sua partecipazione diretta a 6.139 azioni. Il premio consiste in azioni vincolate che maturano il 25% ogni anno a partire dal primo anniversario della concessione, favorendo un allineamento a lungo termine con gli azionisti. Non sono stati esercitati derivati né sono state vendute o trasferite azioni. L'incremento aumenta la quota della direttrice di circa il 13%, ma rappresenta meno dello 0,01% delle azioni in circolazione della società, quindi la diluizione e l'impatto sul mercato sono trascurabili. Sebbene l'accumulo interno sia un segnale positivo, il valore economico è modesto e non modifica sostanzialmente la struttura del capitale o la tesi di investimento di CRAI.

Presentación del Formulario 4 de CRA International (CRAI): La directora Christine Rose Detrick recibió 696 acciones comunes el 17 de julio de 2025 a $0, elevando su propiedad directa a 6,139 acciones. La concesión consiste en acciones restringidas que se consolidan en un 25% anual a partir del primer aniversario de la adjudicación, promoviendo una alineación a largo plazo con los accionistas. No se ejercieron derivados ni se vendieron o transfirieron acciones. Esta adición incrementa la participación de la directora en aproximadamente un 13%, pero representa menos del 0,01% de las acciones en circulación de la compañía, por lo que la dilución y el impacto en el mercado son insignificantes. Aunque la acumulación interna es un indicio positivo, el valor económico es modesto y no altera materialmente la estructura de capital ni la tesis de inversión de CRAI.

CRA International (CRAI) Form 4 제출: 이사 Christine Rose Detrick� 2025� 7� 17일에 보통� 696주를 $0� 수령하여 직접 소유 지분을 6,139주로 늘렸습니�. � 수여� 제한 주식으로, 부여일로부� 1주년부� 매년 25%� 베스팅되� 주주와� 장기적인 정렬� 장려합니�. 파생상품 행사� 없었� 주식� 매도 또는 이전되지 않았습니�. 이번 추가� 이사� 지분은 � 13% 증가했으�, 회사� 발행 주식 총수� 0.01% 미만� 해당하여 희석 � 시장 영향은 미미합니�. 내부� 매입은 긍정적인 신호이나 경제� 가치는 크지 않아 CRAI� 자본 구조� 투자 논리� 실질적인 변화를 주지 않습니다.

Dépôt du Formulaire 4 de CRA International (CRAI) : La directrice Christine Rose Detrick a reçu 696 actions ordinaires le 17 juillet 2025 à 0 $, portant sa participation directe à 6 139 actions. Cette attribution concerne des actions restreintes qui acquièrent 25 % de droits chaque année à partir du premier anniversaire de la remise, favorisant un alignement à long terme avec les actionnaires. Aucun dérivé n’a été exercé et aucune action n’a été vendue ou transférée. Cette augmentation porte la participation de la directrice à environ 13 %, mais représente bien moins de 0,01 % des actions en circulation de la société, rendant la dilution et l’impact sur le marché négligeables. Bien que l’accumulation interne soit un signe positif, la valeur économique reste modeste et ne modifie pas de manière significative la structure du capital ni la thèse d’investissement de CRAI.

CRA International (CRAI) Form 4 Einreichung: Direktorin Christine Rose Detrick erhielt am 17. Juli 2025 696 Stammaktien zu $0, wodurch ihr Direktbesitz auf 6.139 Aktien anstieg. Die Zuteilung besteht aus eingeschränkten Aktien, die ab dem ersten Jahrestag der Gewährung jährlich zu 25 % freigegeben werden, um eine langfristige Ausrichtung an den Aktionären zu fördern. Es wurden keine Derivate ausgeübt und keine Aktien verkauft oder übertragen. Die Hinzufügung erhöht den Anteil der Direktorin um etwa 13 %, stellt jedoch weniger als 0,01 % der ausstehenden Aktien des Unternehmens dar, sodass Verwässerung und Markteinfluss vernachlässigbar sind. Obwohl die Insider-Akkumulation positiv zu werten ist, ist der wirtschaftliche Wert moderat und ändert die Kapitalstruktur oder Investmentthese von CRAI nicht wesentlich.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Detrick Christine Rose

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CRA INTERNATIONAL, INC. [ CRAI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/17/2025 A 696(1) A $0 6,139 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares vest in four equal annual installments beginning on the first anniversary of the date of grant.
Delia J. Makhlouta, by power of attorney 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CRAI disclose on the 21-Jul-2025 Form 4?

Director Christine Rose Detrick was granted 696 restricted shares of CRAI common stock on 17 Jul 2025.

How many CRAI shares does Director Detrick now own?

Following the grant, she beneficially owns 6,139 shares directly.

At what price were the new CRAI shares acquired?

The shares were issued at $0 under a restricted stock award—no cash outlay was required.

What is the vesting schedule for the 696 restricted shares?

They vest in four equal annual installments beginning one year after the 17 Jul 2025 grant date.

Does the filing include any derivative securities or sales?

No. Only non-derivative stock was reported and no shares were sold or disposed.
Cra Intl Inc

NASDAQ:CRAI

CRAI Rankings

CRAI Latest News

CRAI Latest SEC Filings

CRAI Stock Data

1.38B
6.54M
4.22%
90.99%
0.82%
Consulting Services
Services-legal Services
United States
BOSTON